Cargando…

Extended Reality Use in Paediatric Intensive Care: A Scoping Review

Background: Extended reality (XR) technology such as virtual and augmented reality is increasingly being utilised in paediatric medicine due to its role in medical education and reported positive impacts on outcomes including pain, anxiety, and sleep. To the author’s knowledge, no previous reviews i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldsworthy, Adrian, Chawla, Jasneek, Baumann, Oliver, Birt, James, Gough, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review of a Large Clinical Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503262/ https://www.ncbi.nlm.nih.gov/pubmed/37437084 http://dx.doi.org/10.1177/08850666231185721

Ejemplares similares

Use of extended reality in sleep health, medicine, and research: a scoping review
por: Goldsworthy, Adrian, et al.
Publicado: (2023)

Treatment Limitation Decisions in Critically Ill Patients With a Malignancy on the Intensive Care Unit
por: van der Zee, Esther N., et al.
Publicado: (2020)

Engaging People in Making History: Impact, Public Engagement and the World Beyond the Campus
por: King, Laura, et al.
Publicado: (2015)

Risk factors for shedding of Salmonella enterica among hospitalized large animals over a 10‐year period in a veterinary teaching hospital
por: Burgess, Brandy A., et al.
Publicado: (2019)

Communication is crucial: Lessons from COVID‐19 vaccination and pregnancy
por: Cole, Christine, et al.
Publicado: (2022)

The efficacy of an extended scope physiotherapy clinic in paediatric orthopaedics
por: O Mir, Marie, et al.
Publicado: (2016)

Staphylococcus aureus Infections in the Paediatric Intensive Care Unit: Illustrated Cases
por: Hon, Kam Lun, et al.
Publicado: (2021)

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
por: Harper, James, et al.
Publicado: (2021)

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo
por: Montes de Oca, Rocio, et al.
Publicado: (2021)

A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies
por: Zitzmann-Kolbe, Sabine, et al.
Publicado: (2023)

A Biparatopic Antibody–Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade
por: DaSilva, John O., et al.
Publicado: (2021)

Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers
por: Klempner, Samuel J., et al.
Publicado: (2021)

Confronting the threat of bioterrorism: realities, challenges, and defensive strategies
por: Green, Manfred S, et al.
Publicado: (2019)

The impact of extended reality on surgery: a scoping review
por: Zhang, James, et al.
Publicado: (2023)

Incorporating fine‐scale environmental heterogeneity into broad‐extent models
por: Graham, Laura J., et al.
Publicado: (2019)

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
por: Grinkevitch, Vera, et al.
Publicado: (2022)

Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization
por: Buongervino, Samantha, et al.
Publicado: (2021)

Spatial transcriptional signatures define margin morphogenesis along the proximal–distal and medio-lateral axes in tomato (Solanum lycopersicum) leaves
por: Martinez, Ciera C, et al.
Publicado: (2020)

A FZD7-specific Antibody–Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models
por: Do, Myan, et al.
Publicado: (2022)

First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer
por: Pegram, Mark D., et al.
Publicado: (2021)

The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy
por: Puttemans, Janik, et al.
Publicado: (2022)

A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
por: Wurm, Melanie, et al.
Publicado: (2021)

Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
por: Gordon, Michael S., et al.
Publicado: (2021)

Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199
por: Wang, Beatrice T., et al.
Publicado: (2021)

Identification and functional annotation of long intergenic non-coding RNAs in Brassicaceae
por: Palos, Kyle, et al.
Publicado: (2022)

Leaf cell-specific and single-cell transcriptional profiling reveals a role for the palisade layer in UV light protection
por: Procko, Carl, et al.
Publicado: (2022)

Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
por: Hooper, Andrea T., et al.
Publicado: (2022)

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors
por: Tomar, Sakshi, et al.
Publicado: (2022)

Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody–drug Conjugate Targeting AXL-expressing Cancers
por: Zammarchi, Francesca, et al.
Publicado: (2022)

Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers
por: Hollmén, Maija, et al.
Publicado: (2022)

DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody–Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models
por: Yamato, Michiko, et al.
Publicado: (2022)

Preclinical Efficacy of BCMA-Directed CAR T Cells Incorporating a Novel D Domain Antigen Recognition Domain
por: Buonato, Janine M., et al.
Publicado: (2022)

Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal Cancer
por: Wang, Peiyin, et al.
Publicado: (2022)

ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors
por: Wiedemeyer, Wolf R., et al.
Publicado: (2022)

Rapid growth of Moso bamboo (Phyllostachys edulis): Cellular roadmaps, transcriptome dynamics, and environmental factors
por: Chen, Ming, et al.
Publicado: (2022)

Diversification of heat shock transcription factors expanded thermal stress responses during early plant evolution
por: Wu, Ting-Ying, et al.
Publicado: (2022)

Anti-VEGF Antibody Protects against Alveolar Exudate Leakage Caused by Vascular Hyperpermeability, Resulting in Mitigation of Pneumonitis Induced by Immunotherapy
por: Iwai, Toshiki, et al.
Publicado: (2021)

Preclinical Evaluation of (225)Ac-Labeled Single-Domain Antibody for the Treatment of HER2(pos) Cancer
por: Rodak, Magdalena, et al.
Publicado: (2022)

Antibody–Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release
por: Kopp, Anna, et al.
Publicado: (2023)

The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
por: Nelson, Michelle H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sgffd3ke74t6hnqlu0mar18f3l